News | Cancer

News

MHRA publishes ‘world first’ decentralised manufacturing guidance

The guidance will inform the manufacture of medicines with a short shelf-life or highly personalised medicines at sites within or in close proximity to hospitals.…

Published: 13 June 2025

Opinion

Supporting pharmacists in improving the care delivered for people with cancer

The Pharmaceutical Journal has launched a cancer ‘hub page’ and educational resources on blood cancer as part of continued partnership with BeiGene.…

Published: 9 June 2025

Promotional content

News

NICE reverses draft guidance to recommend targeted therapy for patients with advanced bowel cancer

The National Institute for Health and Care Excellence said the treatment should be available on the NHS after the manufacturer provided additional clinical evidence.…

Published: 24 April 2025

News

NICE recommends capivasertib for advanced breast cancer

Clinical trial results revealed that capivasertib, taken with fulvestrant, can provide advanced breast cancer patients with an additional four months before their cancer progresses.…

Published: 11 April 2025

News

NICE approves first NHS treatment for advanced blood cancer

Brentuximab combination therapy is a first-line treatment option for previously untreated stage 3 or 4 CD30-positive Hodgkin lymphoma that could benefit up to 800 people annually.…

Published: 4 April 2025

News

Community pharmacies in England could offer ‘catch-up’ HPV vaccinations

Updated NHS plans to eliminate cervical cancer have suggested community pharmacy as a location for catch-up vaccinations to improve access to the HPV vaccine.…

Published: 2 April 2025

Feature

Engineering precision: developing the next generation of antibody drug conjugates

Researchers are working to create a new generation of these targeted cancer therapies to improve efficacy and minimise off-target adverse effects.…

Published: 15 January 2025

News

NICE recommends olaparib for advanced breast cancer in final draft guidance

The drug has previously been recommended for some types of ovarian cancer in England and for prostate cancer in Scotland.…

Published: 13 January 2025

Feature

BRUKINSA is now reimbursed across the UK for R/R MZL

Read more to learn how BRUKINSA could benefit your patients with R/R MZL.…

Published: 13 January 2025

Promotional content

News

Health inequalities included in updated cancer referral guidelines

The Scottish government's ‘Cancer Strategy for Scotland 2023–2033’ highlights that there is “convincing evidence” that socioeconomic and health disparities are linked with increased diagnoses of more advanced cancers.…

Published: 8 January 2025